With patented technologies and products in the field of aesthetic and regenerative medicine, Human Med AG is a market leader in the treatment of fat distribution disorders in an industry with very high growth potential. Its patented WAL (waterjet-assisted liposuction) technology is one of the gentlest forms of liposuction. Human Med is also the world’s leading technology company for the extraction of autologous fat. This innovative procedure is suitable for numerous follow-up applications (breast reconstruction, wound treatment, etc.) where the body’s natural fat is reused.

Investment procedure

Strategic priorities were defined at the start of the investment. In addition to expanding its market leadership, the aim is to further promote the growth potential of Human Med AG – both in existing markets and in new markets due to new areas of application in regenerative medicine. PREMIUM is the majority shareholder.

Strategic and operational measures

• Expansion into new areas of medical application

• Focusing sales and marketing on the most important markets and customer groups 

• Expansion of the organisation and capacities as a prerequisite for realising high growth potential

Milestones in the company's development

• Succession solution with a new buy-in CEO

• Completion of the management team

heinekingmedia is the digitalisation partner for educational institutions and companies – and a fast-growing hidden champion in the industry with a broad distribution network.

As a pioneer in the field of collaborative hardware and software solutions (UCC/Unified Communications and Collaboration), heinekingmedia uses proprietary products and services to optimise information and communication processes in the classroom and for distance learning, as well as in virtual meeting rooms. More than 1.5 million school children already use GDPR-compliant mobile apps, messaging apps and collaborative software solutions from the market leader – in part thanks to their user-friendly systems.

Investment procedure

heinekingmedia is the second investment of the PREMIUM SME II fund. As the majority shareholder, PREMIUM works closely with the management. At the start of the investment, PREMIUM defined the strategic priorities together with the management and advisory board. Brand recognition and sales are to be increased and the development of innovative software and content solutions intensified.

Strategische und operationelle Maßnahmen

• Solution for operational succession with new buy-in CEO

• Expansion of R&D activities

• Increased marketing presence in schools, school authorities and companies

Meilensteine der Unternehmensentwicklung

• Geographical expansion into Switzerland and Austria through an add-on acquisition

• Strategic partnerships with content providers

• Establishment of a separate R&D unit

ic! berlin has become one of the most well-known German eyewear brands in the premium price segment. As a pioneer in extra-light metal eyewear, ic! berlin sunglasses and corrective eyewear are known for their design, high manufacturing quality and outstanding comfort, as well as patented screwless joints. In addition to metal glasses, its product portfolio also includes acetate frames – manufactured in-house in Berlin. ic! berlin takes care of development, design, manufacturing and sales to leading opticians and distributors, and has its own flagship store.

Investment procedure

ic! berlin is the first investment of the two PREMIUM SME funds launched with Bankhaus Lampe. As the majority shareholder, PREMIUM works closely with the management, which was also involved in the transaction. Management, the advisory board and PREMIUM defined the strategic priorities at the start of the investment. There is a particular focus on enhancing brand recognition and driving international sales.

Strategic and operational measures

• Expansion of the sales team, hiring a new CSO/CMO

• Joint venture with a leading Chinese luxury eyewear retail chain

• Introduction of LEAN processes

Milestones in the company’s development

• Introduction to the Chinese market

• Unbeatable delivery times thanks to significant reduction in production lead times